Federal appeals court blocks mailing of abortion pills in ruling with nationwide effect

A federal appeals court blocked the mailing of the abortion pill mifepristone under FDA rules, citing safety concerns and state authority, with a nationwide effect. The ruling requires in-person prescriptions for mifepristone, reversing pandemic-era changes, and sets up a potential Supreme Court challenge over abortion access.